Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial (GABLE)

NCT06319027 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.

NCT NCT06319027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06319027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial (GABLE)
Lead sponsor
ECOG-ACRIN Cancer Research Group
Phase
Phase 2
Overall status
Recruiting
Start date
April 11, 2024
Completion date
May 31, 2027
Enrollment
100 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, idh-wildtype